leptin and glp 1 GLP-1 Increases Circulating Levels in Truncal Vagotomized Rats Optimizing Fat Loss Hormones |

p 30 leukocytes/HPF

Gastrointestinal symptoms that some patients experience while on GLP-1 therapysuch as nausea, reduced appetite, or altered bowel habitsgenerally resolve as the medication clears from the system, typically within 1-2 weeks for short-acting formulations and within 4-8 weeks for long-acting preparations, corresponding to their elimination timelines

Patients should monitor their symptom patterns and discuss timing adjustments with their healthcare provider if side effects are limiting treatment adherence

Their complementary mechanisms one acting primarily through growth factor upregulation and GI-cytoprotection, the other through actin polymerization and systemic cell migration make them uniquely interesting both individually and as a combined research subject

doi: 10.1007/BF02439268